Contegra Pulmonary Valved Conduit
for Pulmonary Replacement and Reconstruction

Contegra is an integrated valved conduit for reconstruction or replacement of the natural right ventricular outflow tract (RVOT) or replacement of a failed homograft or composite pulmonary conduit. This device has been approved as a humanitarian use device (HUD) in the United States.

Download Product Brochure

Overview

Versatile. Convenient. The natural choice.

Product Details

Natural

  • Derived from a bovine jugular vein
  • Flexible for unique tailoring as only natural tissue can offer
  • Blood passes easily across a continuous tissue interface and natural sinus
  • Thin, extensible tissue is especially suited for anastomosis

Versatile

  • Easily customized to individual needs 
  • Proximal length allows for infundibular shaping without patching
  • Resilient wall retains suture and supports hemostatic suture line

Convenient

  • No additional material necessary for proximal anastomosis
  • Readily available — no thawing or preclotting required

Product Ordering Information

Part Number

Internal Diameter (Inflow End)

200H12

12 mm

200H14

14 mm

200H16

16 mm

200H18

18 mm

200H20

20 mm

Model 01-0055: Torque Wrench (Optional, reusable jar opener)

HUD — Humanitarian Use Device

Humanitarian Use Device: Authorized by federal law for use in patients under 19 years of age for correction or reconstruction of the right ventricular outflow tract (RVOT) in the following congenital heart malformations: pulmonary stenosis, Tetralogy of Fallot, truncus arteriosus, transposition with ventricular septal defect (VSD), pulmonary atresia. In addition, the Contegra pulmonary valved conduit is indicated for the replacement of previously implanted dysfunctional pulmonary homografts or valved conduits. The effectiveness of this device for these uses has not been demonstrated.

Additional Resources

Contact Information

LifeLine CardioVascular
Technical Support

877-526-7890

Send Us an Email

Medtronic
Academy

Training, education, and collaboration on the treatment of valve disease.

Register Here